Application of unilateral biportal endoscopy in minimally invasive treatment of non-aggressive spinal benign tumors: technical note and preliminary clinical study - Scorecard - MDSpire
Advertisement
Application of unilateral biportal endoscopy in minimally invasive treatment of non-aggressive spinal benign tumors: technical note and preliminary clinical study
Clinical Scorecard: Utilization of Unilateral Biportal Endoscopy for Minimally Invasive Management of Non-Aggressive Benign Spinal Tumors: A Technical Overview and Initial Clinical Findings
At a Glance
Category
Detail
Condition
Non-aggressive spinal benign tumors
Key Mechanisms
Unilateral biportal endoscopy (UBE) for tumor resection
Target Population
Patients with pathologically confirmed non-aggressive spinal benign tumors
Care Setting
Chongqing University Cancer Hospital
Key Highlights
14 patients underwent UBE surgery with no tumor recurrence observed during follow-up
Mean operative duration was 77.5 minutes with a mean blood loss of 17.5 mL
Significant improvement in VAS scores at all postoperative timepoints compared to preoperative values
All patients resumed normal daily activities post-surgery
UBE represents a minimally invasive option for managing non-aggressive spinal benign tumors
Guideline-Based Recommendations
Diagnosis
Pathological confirmation of spinal benign tumors is required
Management
UBE is recommended for non-aggressive benign spinal tumors classified as Enneking Stage S1 and S2
Monitoring & Follow-up
Follow-up for tumor recurrence and assessment of clinical outcomes is necessary
Risks
Potential for postoperative complications, although none were reported in this study
For many referring providers, sending a patient for orthopedic care is not just about clinical expertise. It comes down to access, speed, and confidence in what happens next. How quickly will the patient be seen? Will they get a clear diagnosis without unnecessary delays? And will care feel coordinated or fragmented?